Evidence map›Paper›PMID 34233610›Full record

ArticleBMC ecology and evolution2021

DeepHBV: a deep learning model to predict hepatitis B virus (HBV) integration sites.

Canbiao Wu, Xiaofang Guo, Mengyuan Li, Jingxian Shen, Xiayu Fu, Qingyu Xie, Zeliang Hou, Manman Zhai, Xiaofan Qiu, Zifeng Cui and 5 more

Open access · goldAbstract read
In one paragraph

Article in BMC ecology and evolution, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Hepatitis B and circadian rhythm of the liver.World journal of gastroenterology · 2022
    Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Canbiao Wu *Institute for Brain Research and Rehabilitation, South China Normal University, Guangzhou, 510631, Guangdong, China.
Xiaofang Guo *Department of Medical Oncology of the Eastern Hospital, the First Affiliated Hospital, Sun Yat-Sen University, Guangdong, 510700, Guangzhou, China.
Mengyuan Li *Department of Gynecological Oncology, the First Affiliated Hospital, Sun Yat-Sen University, Guangdong, 510080, Guangzhou, China.
Jingxian Shen *Institute for Brain Research and Rehabilitation, South China Normal University, Guangzhou, 510631, Guangdong, China.
Xiayu FuDepartment of Thoracic Surgery, the First Affiliated Hospital, Sun Yat-Sen University, Guangdong, 510080, Guangzhou, China.
Qingyu XieInstitute for Brain Research and Rehabilitation, South China Normal University, Guangzhou, 510631, Guangdong, China.
Zeliang HouInstitute for Brain Research and Rehabilitation, South China Normal University, Guangzhou, 510631, Guangdong, China.
Manman ZhaiInstitute for Brain Research and Rehabilitation, South China Normal University, Guangzhou, 510631, Guangdong, China.
Xiaofan QiuInstitute for Brain Research and Rehabilitation, South China Normal University, Guangzhou, 510631, Guangdong, China.
Zifeng CuiDepartment of Gynecological Oncology, the First Affiliated Hospital, Sun Yat-Sen University, Guangdong, 510080, Guangzhou, China.
Hongxian XieGenerulor Company Bio-X Lab, Guangzhou, 510006, Guangdong, China.
Pengmin QinSchool of Psychology, South China Normal University, Guangzhou, 510080, Guangdong, China.
Xuchu WengInstitute for Brain Research and Rehabilitation, South China Normal University, Guangzhou, 510631, Guangdong, China.
Zheng HuDepartment of Gynecological Oncology, the First Affiliated Hospital, Sun Yat-Sen University, Guangdong, 510080, Guangzhou, China. huzheng1998@163.com.
Jiuxing LiangInstitute for Brain Research and Rehabilitation, South China Normal University, Guangzhou, 510631, Guangdong, China. liangjiuxing@m.scnu.edu.cn.
South China Normal University · CNThe First Affiliated Hospital, Sun Yat-sen University · CNSun Yat-sen University · CNGuangzhou Regenerative Medicine and Health Guangdong Laboratory · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe hepatitis B virus (HBV) is one of the main causes of viral hepatitis and liver cancer. HBV integration is one of the key steps in the virus-promoted malignant transformation.

resultsAn attention-based deep learning model, DeepHBV, was developed to predict HBV integration sites. By learning local genomic features automatically, DeepHBV was trained and tested using HBV integration site data from the dsVIS database. Initially, DeepHBV showed an AUROC of 0.6363 and an AUPR of 0.5471 for the dataset. The integration of genomic features of repeat peaks and TCGA Pan-Cancer peaks significantly improved model performance, with AUROCs of 0.8378 and 0.9430 and AUPRs of 0.7535 and 0.9310, respectively. The transcription factor binding sites (TFBS) were significantly enriched near the genomic positions that were considered. The binding sites of the AR-halfsite, Arnt, Atf1, bHLHE40, bHLHE41, BMAL1, CLOCK, c-Myc, COUP-TFII, E2A, EBF1, Erra, and Foxo3 were highlighted by DeepHBV in both the dsVIS and VISDB datasets, revealing a novel integration preference for HBV.

conclusionsDeepHBV is a useful tool for predicting HBV integration sites, revealing novel insights into HBV integration-related carcinogenesis.

Indexed as

Carcinoma, HepatocellularDeep LearningDNA, ViralHepatitis B virusHumansVirus IntegrationDNA, ViralBioinformaticsDeep learningGenomic featuresHBV integration sites

Identifiers

PMID34233610
PMCPMC8261932
OpenAlexW3182709031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.